214 related articles for article (PubMed ID: 20674253)
21. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy.
Harrison LE; Bryan M; Pliner L; Saunders T
Ann Surg Oncol; 2008 May; 15(5):1407-13. PubMed ID: 18157576
[TBL] [Abstract][Full Text] [Related]
23. Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Sironi A; Cabras A; Fumagalli L; Laterza B; Deraco M
In Vivo; 2008; 22(1):153-7. PubMed ID: 18396799
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH
J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862
[TBL] [Abstract][Full Text] [Related]
25. Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy.
Chua TC; Baker B; Yan TD; Zhao J; Morris DL
Am J Clin Oncol; 2010 Dec; 33(6):568-71. PubMed ID: 20019578
[TBL] [Abstract][Full Text] [Related]
26. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
Gilly FN; Beaujard A; Glehen O; Grandclement E; Caillot JL; Francois Y; Sadeghi-Looyeh B; Gueugniaud PY; Garbit F; Benoit M; Bienvenu J; Vignal J
Anticancer Res; 1999; 19(3B):2317-21. PubMed ID: 10472351
[TBL] [Abstract][Full Text] [Related]
27. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
[TBL] [Abstract][Full Text] [Related]
28. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M
Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276
[TBL] [Abstract][Full Text] [Related]
30. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
[TBL] [Abstract][Full Text] [Related]
32. Results of treatment of 33 patients with peritoneal mesothelioma.
Sebbag G; Yan H; Shmookler BM; Chang D; Sugarbaker PH
Br J Surg; 2000 Nov; 87(11):1587-93. PubMed ID: 11091251
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.
Glehen O; Cotte E; Schreiber V; Sayag-Beaujard AC; Vignal J; Gilly FN
Br J Surg; 2004 Jun; 91(6):747-54. PubMed ID: 15164446
[TBL] [Abstract][Full Text] [Related]
35. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
[TBL] [Abstract][Full Text] [Related]
36. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.
Franko J; Gusani NJ; Holtzman MP; Ahrendt SA; Jones HL; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2008 Nov; 15(11):3065-72. PubMed ID: 18712450
[TBL] [Abstract][Full Text] [Related]
37. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
38. The management of peritoneal surface malignancy of colorectal cancer origin.
Tentes AA
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s39-42. PubMed ID: 15655638
[TBL] [Abstract][Full Text] [Related]
39. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
Kusamura S; Deraco M; Baratti D; Inglese MG; Costanzo P; Favaro M; Manzi R; Gavazzi C
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):207-12. PubMed ID: 16767933
[TBL] [Abstract][Full Text] [Related]
40. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
